Neu Health Joins Global Incubator for U.S. Expansion in Neurology

September 12, 2025
Neu Health has been selected for the Global Incubator Programme to expand its precision neurology platform for Parkinson's and dementia care in the U.S., announced in a press release.

Neu Health has been selected for the Global Incubator Programme (GIP): USA HealthTech - Medical Devices, announced in a press release. This six-month program, delivered by Innovate UK in partnership with Texas Medical Center Innovation (TMCi), aims to support UK medical device and digital health companies entering the U.S. market.

The program provides access to Houston's Texas Medical Center, the world's largest medical complex, which treats 10 million patients annually. This selection follows Neu Health's recent U.S. launch and FDA 510(k) clearance for its smartphone-based tool for measuring resting tremor in Parkinson's disease. The tool is the first fully phone-based system for measuring motor symptoms without wearable or in-clinic hardware.

Neu Health is already piloting its platform at Cedars-Sinai and Mass General Brigham, with further U.S. expansions planned. The GIP will enable Neu Health to connect with clinical leaders and investor networks, facilitating partnerships and growth opportunities in the U.S. market. The program runs from September 2025 to March 2026, combining virtual incubation with on-site immersion in Houston.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Life Sciences

09/12
Imaging Endpoints Files Patent for AI-Enhanced Imaging Review System
09/12
Homecare Homebase and Element5 Partner to Enhance Post-Acute Care with AI
09/12
University of Utah Partners with HPE and NVIDIA for AI Research
09/12
uLab and Biolux Partner to Enhance Clear Aligner Therapy
09/12
Eko Health's AI Stethoscope Enhances Heart Disease Detection

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Whitepaper

Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation

The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.

Read more

You May Also Like